海外の治験の状況「前立腺癌」での検索結果
254件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage
- Prostate Cancer
- Israel
- 2019-09-11
Recruiting
- Active Surveillance for Low Risk Prostate Cancer
- Prostate Cancer;Prostate Adenocarcinoma
- Russian Federation
- 2019-10-28
Recruiting
- 177Lu-PSMA-I&T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- China
- 2019-12-04
Recruiting
- Extracorporeal Focused Ultrasound Surgery for Prostate Cancer: a Feasibility and Safety Study
- Prostate cancer
- China
- 2020-01-01
Recruiting
- Multi-center prospective clinical study of prostate cancer antigen (PCA3) combined with fusion gene detection used in the diagnosis and risk stratification prediction of prostate cancer
- Prostate Cancer
- China
- 2017-08-10
Recruiting
- A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer # Prostate Cancer # Cancer of the Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Province of China, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2015-06-23
Recruiting
- Hormonal therapy with or without docetaxel in treating patients with high-volume metastatic prostate cancer
- prostate cancer
- China
- 2015-01-06
Recruiting
- DNA-repair defects and Platinum-based chemotherapy in metastatic castration-resistant prostate cancer
- prostate cancer
- China
- 2016-10-23
Recruiting
- Phase II Trial of Pembrolizumab (MK-3475) in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Chemotherapy (KEYNOTE-199)
- Metastatic Castration-resistant Prostate Cancer (mCRPC);C61 - Malignant neoplasm of prostate
- Australia, Canada, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Spain, Sweden, Switzerland, Taiwan, Province of China, Turkey, United Kingdom, United States
- 2016-10-17
Recruiting
- Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer
- Metastatic Prostate Carcinoma;Metastatic Prostate Carcinoma
- China
- 2016-10-11